Shift From Adalimumab Originator to Biosimilars in Denmark
Author(s) -
Thomas Bo Jensen,
Seoyoung C. Kim,
Espen JimenezSolem,
Dorthe Bartels,
Hanne Rolighed Christensen,
Jón Trærup Andersen
Publication year - 2020
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2020.0338
Subject(s) - biosimilar , medicine , adalimumab , competition (biology) , market competition , family medicine , pharmacology , rheumatoid arthritis , ecology , economics , market economy , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom